Every Man Deserves Better Answers
PSA and Gleason give necessary insight into your cancer’s current state, but Prolaris can provide you with a clear outlook of the behavior of your prostate cancer over the next 10 years.
Prolaris is a clinically proven, accurate genetic test designed to help patients understand the true nature of their prostate cancer. Prolaris will help guide treatment decisions and provide results that show how aggressively the cancer is progressing. It is time to feel confident about prostate cancer treatment decisions.
To learn more about the Prolaris test and how it works:
Watch Al’s story of his prostate cancer diagnosis and how testing with Prolaris gave him answers to questions he didn’t even know to ask.
The battle begins with diagnosis, but the way patients fight that battle vary drastically.
While prostate cancer is a common diagnosis, it’s important to understand that not all prostate cancers are the same. Fortunately, because most prostate cancers are slow growing and not aggressive, 98% of men will survive over a 5-year span.1
With Prolaris you can learn more about the behavior of your specific tumor. Receiving a Prolaris Score will give you and your doctor increased confidence in making a more informed decision about your treatment.
When to Test with Prolaris
Any patient diagnosed with prostate cancer is a good candidate for Prolaris testing. Since all men with prostate cancer have already received a prostate biopsy, there is no need to undergo any additional biopsies in order to get testing with Prolaris because that first biopsy tissue is used.
How the Testing Process Works
Your prostate tissue sample from your biopsy will be sent to Myriad.
Testing & Analysis
The tissue is tested and analyzed to determine the aggressiveness of your prostate cancer.
Once the sample(s) have been processed, the results are sent directly to your physician. The results will contain your personalized Prolaris Score, as well as your risk of dying from your prostate cancer or having the cancer spread outside the prostate within the next ten years.
Benefits of Testing
1. National Cancer Institute (NIH). Cancer Stat Facts: Prostate Cancer. Surveillance, Epidemiology, and End Results Program. https://seer.cancer.gov/statfacts/html/prost.html